Navigation Links
MiMedx Group Announces Third Quarter 2011 Results
Date:10/26/2011

earance for its first CollaFix™ product or that such clearance may be delayed, that, once clearance is received,  the anticipated demand for the product may not materialize, that the Company may not be successful in ramping up its production capabilities to meet the demand for its initial CollaFix™ product, and the risk factors detailed from time to time in the Company's periodic Securities and Exchange Commission filings, including, without limitation, its 10-K filing for the fiscal year ended December 31, 2010, and its most recent Form 10-Q. By making these forward-looking statements, the Company does not undertake to update them in any manner except as may be required by the Company's disclosure obligations in filings it makes with the Securities and Exchange Commission under the federal securities laws. MIMEDX GROUP, INC. AND SUBSIDIARIESCONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)Three Months Ended September 30,Nine Months Ended September 30,2011201020112010REVENUES:Net sales$
2,152,094$
8,027$
5,124,980$
544,956OPERATING COSTS AND EXPENSES:Cost of products sold843,366539,6972,291,6471,355,210Research and development expenses485,236842,9291,995,6262,168,043Selling, general and administrative expenses2,475,8491,579,2598,162,8475,121,933LOSS FROM OPERATIONS(1,652,357)(2,853,858)(7,325,140)(8,100,230)OTHER INCOME (EXPENSE), netInterest (expense) income, net(113,366)(584)(291,651)(592,866)LOSS BEFORE INCOME TAXES(1,765,723)(2,854,442)(7,616,791)(8,693,096)Income taxes----NET LOSS$
(1,765,723)$
(2,854,442)$
(7,616,791)$
(8,693,096)Net loss per common shareBasic and diluted$
(0.02)$
(0.05)$
(0.11)$
(0.15)Shares used in computing net loss per common shareBasic and diluted73,767,67461,049,94272,082,60557,874,093See notes to condensed consolidated financial statementsMIMEDX GROUP, INC. AND SUBSIDIARIESCONDENSED CONSOLIDATED BALANCE SHEETSASSETSSeptember 30,2011December 31,(unaudited)2010Current assets:C
'/>"/>
SOURCE MiMedx Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. MiMedx Groups EpiFix® Receives American Podiatric Medical Association Seal of Approval
2. MiMedx Group Partners With Affirmative Solutions
3. MiMedx Group Receives FDA Clearance to Market Its HydroFix™ Ortho Shield™ Device
4. MiMedx Announces Launch of AmnioFix™ Nerve Wrap
5. MiMedx to Attend International Society for the Advancement of Spine Surgery Annual Meeting
6. MiMedx Group, Inc. Announces Release Date for First Quarter Results
7. MiMedx Completes Acquisition of Surgical Biologics
8. MiMedx Receives Additional CE Certification for Its HydroFix™ Technology
9. MiMedx Announces Agreement to Acquire Surgical Biologics
10. MiMedx Group, Inc. Announces Release Date for Second Quarter Results
11. MiMedx Group Announces Addition of Sales Director for Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... -- ConvaTec, a privately-held medical products and technologies company, today ... Executive Officer of the company, effective December 22, 2014. ... "The Board of Directors of ConvaTec thanks Mr. Berger ... three years," said Magnus Lundberg , the Chairman ... the company is well positioned for the future."  The ...
(Date:12/22/2014)... and STOCKHOLM , Dec. ... (Sobi) and partner Auxilium Pharmaceuticals, Inc. today announced that ... of the European Medicines Agency (EMA) has adopted a ... histolyticum) for the treatment of adult men with Peyronie,s ... at least 30 degrees at the start of therapy. ...
(Date:12/22/2014)... , Dec. 22, 2014  Mark Farrah ... brief providing a summary of the 2015 marketplace ... enrollment trends.  According to a ... Planning and Evaluation, Department of Health and Human ... enrolled in individual medical plans through the Marketplace ...
Breaking Medicine Technology:ConvaTec Names Paul Moraviec Interim CEO Effective December 22, 2014 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 3Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 4Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 5Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 6Insights into the Marketplace and Individual Market Growth 2
... Solos Endoscopy, Inc. (OTCPK: SNDY) announced today that the ... one hundred fifty million (150,000,000) common shares held by ... Convertible Preferred Shares. The common shares held by the ... back to the Company treasury. This transaction represents a ...
... Va., Feb. 14, 2012 The 60 Plus Association ... to weigh in with the Federal Trade Commission (FTC) ... and Medco Health Solutions, two pharmacy benefit managers (PBMs) ... some Medicare Part D plans. 60 Plus is a ...
Cached Medicine Technology:Solos Endoscopy, Inc. Announces Retirement of 150 Million Common Shares 2The 60 Plus Association Asks Congressional Leaders To Weigh In Against Controversial Health Care Merger 2
(Date:12/26/2014)... Pentec Health, Inc. number fourteen on the Best ... 2014. The awards program, created in 2000, is one ... the country. The program is a public/private partnership between ... Economic Development, the Pennsylvania State Council of the Society ... Journal. , Charlie Wilson, Vice President of ...
(Date:12/25/2014)... 2014 The microscopy market is ... to reach $5,756.0 million by 2019. Optical microscopy ... The electron microscopes product segment is expected to ... , Rising focus on nanotechnology, technological advancements, and ... microscopy market. , Get Full Copy of Report ...
(Date:12/25/2014)... The report “Nintedanib (Colorectal Cancer) ... on the current treatment landscape, unmet needs, current ... market. Stivarga is a drug which is used ... Boehringer Ingelheim is developing nintedanib (BIBF-1120), an orally ... CRC in the US, Europe, and Japan. The ...
(Date:12/25/2014)... months the trends for evening dresses shift and ... of the hottest styles in the next few months.” The ... 26 A-line sweetheart evening dresses, and announces the availability of ... trying our best to help a lady to show off ... prices, we provide discounted delivery costs to our customers worldwide. ...
(Date:12/25/2014)... (PRWEB) December 25, 2014 The short film ... was created in honor of a true 9/11 hero, Welles ... film festivals including the 24 hours of Nuremberg International Short ... Bangladesh. , Actress, screenwriter and director Luciana Lagana ... this film together with her husband, Gregory Graham ...
Breaking Medicine News(10 mins):Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 2Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3
... 30 Contrary to prevailing,assumptions, children are more vulnerable ... of 6 than they are in early childhood, according ... presented May 4,at the annual meeting of the Pediatric ... about protecting toddlers from lead,exposure, our study shows that ...
... members, PHOENIX, April 30 Gov. Janet ... the state Medicaid program to,expend moneys to provide ... by Sen. Barbara Leff (R-Paradise Valley), SB 1418 ... Fund and will provide benefits,for nicotine replacement therapies ...
... heart rate variability, researchers report, , , WEDNESDAY, April 30 ... that the electromagnetic field produced by incubators affect the ... Whether these changes in cardiac rhythms have long-term effects ... infants who can spend several weeks or months in ...
... and Their Contacts, Underscored by Research Led by ... April 30 The high costs of hospitalizing,young ... in the,United States, underscoring the importance of preventive ... they have regular contact, according to,research led by ...
... -- Pelvic organ prolapse a tear or weakness in ... to fall outside the body runs in families, a ... family member who has had a hernia or prolapse ... body opening are more likely to develop prolapse themselves, says ...
... Osteotech, Inc.,(Nasdaq: OSTE ), a leader in ... announced today that it has signed an exclusive,distribution ... 1,2008, under which BioHorizons will market Osteotech,s bone ... in Europe, the Middle East,Latin America and Asia. ...
Cached Medicine News:Health News:Children More Vulnerable to Harmful Effects of Lead at Age 6 Than as Toddlers, Says New Study 2Health News:Children More Vulnerable to Harmful Effects of Lead at Age 6 Than as Toddlers, Says New Study 3Health News:Governor Napolitano Signs Smoking Cessation Bill 2Health News:Incubators Affect Newborns' Heart Rates 2Health News:Young Children Hospitalized for Flu Associated With Higher Costs and Higher Risk Illness 2Health News:Young Children Hospitalized for Flu Associated With Higher Costs and Higher Risk Illness 3Health News:Family history places women at risk of pelvic organ prolapse, SLU research finds 2Health News:Osteotech Engages BioHorizons as Exclusive Distributor to International Dental Market 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: